CRISPR遺伝子編集市場：提供、技術、用途、最終用途別-世界予測2025-2030年

CRISPR遺伝子編集市場は、2023年に32億5,000万米ドルと評価され、2024年には37億7,000万米ドルに達すると予測され、CAGR 16.81%で成長し、2030年には96億6,000万米ドルに達すると予測されています。

CRISPR遺伝子編集は、遺伝子配列の正確な改変を可能にする革新的な技術であり、バイオテクノロジーと医療に革命をもたらしています。CRISPRの適用範囲は農業から医薬品にまで及び、遺伝的障害に対処し、作物の耐性を強化し、バイオテクノロジーの進歩に貢献する可能性があります。CRISPRの必要性は、遺伝子コードを正確に標的化して編集するその能力から生じ、遺伝子研究や治療開発に不可欠なものとなっています。CRISPRの用途には、遺伝子治療、遺伝病モデリング、創薬、農業用遺伝子組み換えなどがあります。主なエンドユーザーは、遺伝子研究や製品開発に携わる学術機関、バイオテクノロジー企業、製薬会社です。

市場の洞察によると、CRISPR市場の成長は、遺伝学およびゲノム研究のための資金調達の増加、CRISPRプラットフォームの技術的進歩、革新的な治療アプローチを必要とする遺伝性疾患の有病率の上昇などの要因によって影響を受けています。精密医療におけるCRISPRアプリケーションの拡大、CRISPRベースの診断法の開発、合成生物学など、ビジネスチャンスは豊富にあります。企業は、研究協力への投資、知的財産ポートフォリオの強化、現在の治療薬以外の応用分野の拡大により、これらの機会を活用することができます。

しかし、倫理的な懸念、規制上のハードル、CRISPR改変に伴う潜在的な標的外影響などにより、市場の成長は限界に直面しています。また、特許状況の複雑さも市場参入者に課題を投げかけています。倫理的な考慮は、一般大衆の受容と規制遵守を確保するための慎重な精査と対話を要求し、一方で現在進行中の研究は、遺伝子編集における特異性の改善と意図しない変異の低減を目指しています。

技術革新と研究に最適な分野としては、CRISPRの精度の向上、in vivo応用のための送達メカニズムの開発、エピジェネティック修飾の探求などが挙げられます。さらに、CRISPRを人工知能やビッグデータ解析と統合することで、研究に深い洞察と効率性をもたらすことができます。市場の性質はダイナミックで急速に進化しており、学際的な共同研究が進展を促進しています。持続的な成長のためには、企業は技術革新と市民参加への強いコミットメントを維持しつつ、倫理的懸念と規制の道筋への対応に注力すべきです。

市場力学：急速に進化するCRISPR遺伝子編集市場における重要な市場洞察の解明

CRISPR遺伝子編集市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 遺伝性疾患に対する新しいワクチンや治療に対するニーズの高まり
  • バイオテクノロジーおよび製薬分野への民間および公的投資の増加
  • 宇宙調査におけるCRISPR遺伝子編集の採用
• 市場抑制要因
  • CRISPR療法の高コスト
• 市場機会
  • CRISPR遺伝子編集の進歩と改良
  • 農業分野でのCRISPR遺伝子編集利用の可能性
• 市場の課題
  • CRISPR遺伝子編集に関する技術的課題と倫理的懸念

ポーターのファイブフォース：CRISPR遺伝子編集市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、CRISPR遺伝子編集市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：CRISPR遺伝子編集市場における外部からの影響の把握

外部マクロ環境要因は、CRISPR遺伝子編集市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析CRISPR遺伝子編集市場における競合情勢の把握

CRISPR遺伝子編集市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCRISPR遺伝子編集市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、CRISPR遺伝子編集市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨CRISPR遺伝子編集市場における成功への道筋を描く

CRISPR遺伝子編集市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患に対する新たなワクチンと治療法の必要性が高まる
    • バイオテクノロジーおよび製薬分野への民間および公的投資の増加
    • 宇宙探査におけるCRISPR遺伝子編集の採用
  • 抑制要因
    • CRISPR療法の高コスト
  • 機会
    • CRISPR遺伝子編集の進歩と改善
    • 農業分野におけるCRISPR遺伝子編集の潜在的な用途
  • 課題
    • CRISPR遺伝子編集に関連する技術的な課題と倫理的な懸念
• 市場セグメンテーション分析
  • テクノロジー：RNA操作を伴うアプリケーションにおけるCRISPR/Cas13の好感度が増加
  • 最終用途：医薬品およびバイオテクノロジー企業における治療法開発と創薬におけるCRISPR遺伝子編集の重要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 CRISPR遺伝子編集市場：提供別

• 試薬・消耗品
• サービス
• ソフトウェアとシステム

第7章 CRISPR遺伝子編集市場：技術別

• 抗CRISPRタンパク質
• クリスパー/Cas13
• クリスパー/Cas9
• CRISPR/Cpf1（Cas12a）

第8章 CRISPR遺伝子編集市場：用途別

• 診断と治療の開発
• 遺伝子工学
  • 動物遺伝子工学
  • 細胞株エンジニアリング
  • 植物遺伝子工学

第9章 CRISPR遺伝子編集市場：最終用途別

• 学術調査機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのCRISPR遺伝子編集市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のCRISPR遺伝子編集市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのCRISPR遺伝子編集市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • SynthegoとSeQure Dxが提携し、CRISPRベースの治療薬開発者向けに包括的なオフターゲット解析サービスを提供
  • CRISPR QC、シリーズA資金調達ラウンドで1,000万米ドルを調達
  • 新興企業Tomeが2億5,000万米ドルの遺伝子編集取引でReplace TXを買収
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• AstraZeneca PLC
• Beam Therapeutics Inc.
• Bio-Rad Laboratories, Inc.
• Caribou Biosciences, Inc.
• Cellectis S.A.
• CRISPR Therapeutics AG
• Danaher Corporation
• Editas Medicine, Inc.
• F. Hoffmann-La Roche AG
• GeneCopoeia, Inc.
• GenScript Biotech Corporation
• Horizon Discovery Group Ltd. by Revvity, Inc.
• Inscripta, Inc.
• Intellia Therapeutics, Inc.
• Lonza Group Ltd.
• Mammoth Biosciences, Inc.
• Merck KGaA
• New England Biolabs, Inc.
• OriGene Technologies, Inc.
• Prime Medicine, Inc.
• Qiagen NV
• Sherlock Biosciences, Inc.
• Thermo Fisher Scientific Inc.
• ToolGen, Inc.

LIST OF FIGURES

• FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
• FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CRISPR GENE EDITING MARKET DYNAMICS
• TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 73. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 78. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 164. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 184. POLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 189. QATAR CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

The CRISPR Gene Editing Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.81%, to USD 9.66 billion by 2030.

CRISPR gene editing is a transformative technology that allows precise alterations to genetic sequences, which is revolutionizing biotechnology and medicine. The scope of CRISPR extends from agriculture to pharmaceuticals, with the potential to address genetic disorders, enhance crop resistance, and contribute to biotechnological advancements. The necessity of CRISPR arises from its ability to precisely target and edit genetic codes, making it indispensable for genetic research and therapy development. Its applications include gene therapy, genetic disease modeling, drug discovery, and agricultural genetic modification. Key end-users are academic institutions, biotechnology firms, and pharmaceutical companies involved in genetic research and product development.

Market insights reveal that the CRISPR market growth is influenced by factors such as increased funding for genetic and genomic research, technological advancements in CRISPR platforms, and rising prevalence of genetic disorders that necessitate innovative therapeutic approaches. Opportunities abound in expanding CRISPR applications in precision medicine, developing CRISPR-based diagnostics, and synthetic biology. Companies can capitalize on these opportunities by investing in research collaborations, strengthening intellectual property portfolios, and expanding application areas beyond current therapeutics.

However, market growth faces limitations due to ethical concerns, regulatory hurdles, and potential off-target effects associated with CRISPR modifications. The complexity of patent landscapes also poses challenges to market entrants. Ethical considerations demand careful scrutiny and dialogue to ensure public acceptance and regulatory compliance, while ongoing research aims to improve specificity and reduce unintended mutations in gene editing.

The best areas for innovation and research include enhancing CRISPR accuracy, developing delivery mechanisms for in vivo applications, and exploring epigenetic modifications. Furthermore, integrating CRISPR with artificial intelligence and big data analytics can provide deeper insights and efficiency in research. The nature of the market is dynamic and rapidly evolving, with significant interdisciplinary collaborations driving progress. For sustained growth, businesses should focus on addressing ethical concerns and regulatory pathways while maintaining a strong commitment to technological innovation and public engagement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Gene Editing Market

The CRISPR Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for new vaccines and treatments for genetic diseases
  • Increasing private and public investments in biotechnological and pharmaceutical sectors
  • Adoption of CRISPR gene editing in space investigation
• Market Restraints
  • High cost of CRISPR therapies
• Market Opportunities
  • Advancements and improvements in CRISPR gene editing
  • Potential use of CRISPR gene editing in the agriculture sector
• Market Challenges
  • Technical challenges and ethical concerns associated with CRISPR gene editing

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Gene Editing Market

A detailed market share analysis in the CRISPR Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CRISPR Gene Editing Market

A strategic analysis of the CRISPR Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
• Based on Technology, market is studied across Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9, and CRISPR/Cpf1 (Cas12a).
• Based on Application, market is studied across Diagnostics & Therapy Development and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genetic Engineering.
• Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
    • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
    • 5.1.1.3. Adoption of CRISPR gene editing in space investigation
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of CRISPR therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and improvements in CRISPR gene editing
    • 5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
  • 5.1.4. Challenges
    • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
  • 5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. CRISPR Gene Editing Market, by Offering

• 6.1. Introduction
• 6.2. Reagents & Consumables
• 6.3. Services
• 6.4. Software & Systems

7. CRISPR Gene Editing Market, by Technology

• 7.1. Introduction
• 7.2. Anti-CRISPR Proteins
• 7.3. CRISPR/Cas13
• 7.4. CRISPR/Cas9
• 7.5. CRISPR/Cpf1 (Cas12a)

8. CRISPR Gene Editing Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics & Therapy Development
• 8.3. Genetic Engineering
  • 8.3.1. Animal Genetic Engineering
  • 8.3.2. Cell Line Engineering
  • 8.3.3. Plant Genetic Engineering

9. CRISPR Gene Editing Market, by End-use

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Pharmaceutical & Biotechnology Companies

10. Americas CRISPR Gene Editing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific CRISPR Gene Editing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa CRISPR Gene Editing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
  • 13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
  • 13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. AstraZeneca PLC
• 3. Beam Therapeutics Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Caribou Biosciences, Inc.
• 6. Cellectis S.A.
• 7. CRISPR Therapeutics AG
• 8. Danaher Corporation
• 9. Editas Medicine, Inc.
• 10. F. Hoffmann-La Roche AG
• 11. GeneCopoeia, Inc.
• 12. GenScript Biotech Corporation
• 13. Horizon Discovery Group Ltd. by Revvity, Inc.
• 14. Inscripta, Inc.
• 15. Intellia Therapeutics, Inc.
• 16. Lonza Group Ltd.
• 17. Mammoth Biosciences, Inc.
• 18. Merck KGaA
• 19. New England Biolabs, Inc.
• 20. OriGene Technologies, Inc.
• 21. Prime Medicine, Inc.
• 22. Qiagen NV
• 23. Sherlock Biosciences, Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. ToolGen, Inc.